Premium
BTNL2 associated with the immune response to hepatitis B vaccination in a Chinese Han population
Author(s) -
Yang Chao,
Pan Liping,
Zhang Li,
Wu Xiaopan,
Zhu Xilin,
Yan Bingyu,
Xu Aiqiang,
Li Hui,
Liu Ying
Publication year - 2014
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.23934
Subject(s) - virology , vaccination , immune system , population , immunology , hepatitis b , biology , medicine , environmental health
No response to hepatitis B vaccination is a complex phenomenon, which is induced by the combinations of environmental and genetic factors. The aim of the study was to investigate the association between the polymorphisms of the butyrophilin‐like 2 (BTNL2) gene and the immune response to hepatitis B vaccination in a Chinese Han population. A total of 7 single nucleotide polymorphisms in the BTNL2 gene were analyzed in 566 non‐responders and 1,040 high‐responders to hepatitis B vaccination. The alleles T, T, C, A, G of rs3763316, rs3763311, rs9268494, rs3806156, and rs2076530 were associated with no response to hepatitis B vaccination ( P = 0.015, odds ratio (OR) = 1.20; P = 0.029, OR = 1.18; P = 2.00E−07, OR = 1.58; P = 0.002, OR = 1.27; P = 2.90E−06, OR = 1.41, respectively). Whereas, the alleles T, C of rs9268501 and rs3763313 played significantly protective roles in the immune response to hepatitis B vaccination ( P = 0.007, OR = 0.81; P = 0.004, OR = 0.74). Besides, the risks of no response to hepatitis B vaccination were increased significantly among individuals harbored the haplotypes of G‐T‐A‐T‐C‐A‐G ( P = 0.038, OR = 1.48), G‐T‐A‐T‐C ( P < 0.0001, OR = 2.34), A‐A ( P < 0.0001, OR = 4.08), and C‐G ( P < 0.0001, OR = 4.75). However, the haplotype of G‐C‐A‐T‐C ( P = 1.00E−04, OR = 0.54) exhibited a protective role in the immune response to hepatitis B vaccination in the study. These findings suggest that polymorphisms in the BTNL2 gene might play a vital role in determining the outcome of the immune response to hepatitis B vaccination. J. Med. Virol. 86:1105–1112, 2014 . © 2014 Wiley Periodicals, Inc.